DK3630967T3 - Protease og bindingspolypeptid for o-glycoproteiner - Google Patents

Protease og bindingspolypeptid for o-glycoproteiner Download PDF

Info

Publication number
DK3630967T3
DK3630967T3 DK18728576.2T DK18728576T DK3630967T3 DK 3630967 T3 DK3630967 T3 DK 3630967T3 DK 18728576 T DK18728576 T DK 18728576T DK 3630967 T3 DK3630967 T3 DK 3630967T3
Authority
DK
Denmark
Prior art keywords
glycoproteins
protease
binding polypeptide
polypeptide
binding
Prior art date
Application number
DK18728576.2T
Other languages
Danish (da)
English (en)
Inventor
Fredrik Leo
Stephan Bjork
Malin Mejare
Fredrik Olsson
Rolf Lood-Alayón
Original Assignee
Genovis Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1708476.5A external-priority patent/GB201708476D0/en
Priority claimed from GBGB1708471.6A external-priority patent/GB201708471D0/en
Priority claimed from GBGB1806655.5A external-priority patent/GB201806655D0/en
Application filed by Genovis Ab filed Critical Genovis Ab
Application granted granted Critical
Publication of DK3630967T3 publication Critical patent/DK3630967T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24057O-Sialoglycoprotein endopeptidase (3.4.24.57), i.e. glycoprotease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/924Hydrolases (3) acting on glycosyl compounds (3.2)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/952Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from bacteria

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
DK18728576.2T 2017-05-26 2018-05-25 Protease og bindingspolypeptid for o-glycoproteiner DK3630967T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1708476.5A GB201708476D0 (en) 2017-05-26 2017-05-26 Tools for glycan analysis
GBGB1708471.6A GB201708471D0 (en) 2017-05-26 2017-05-26 Polypeptide
GBGB1806655.5A GB201806655D0 (en) 2018-04-24 2018-04-24 Polypeptide
PCT/EP2018/063832 WO2018215656A1 (en) 2017-05-26 2018-05-25 Protease and binding polypeptide for o-glycoproteins

Publications (1)

Publication Number Publication Date
DK3630967T3 true DK3630967T3 (da) 2024-08-19

Family

ID=62492612

Family Applications (2)

Application Number Title Priority Date Filing Date
DK18728577.0T DK3630968T3 (da) 2017-05-26 2018-05-25 Enzymer til glycananalyse
DK18728576.2T DK3630967T3 (da) 2017-05-26 2018-05-25 Protease og bindingspolypeptid for o-glycoproteiner

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK18728577.0T DK3630968T3 (da) 2017-05-26 2018-05-25 Enzymer til glycananalyse

Country Status (14)

Country Link
US (3) US12448614B2 (enExample)
EP (2) EP3630968B8 (enExample)
JP (3) JP7195008B2 (enExample)
KR (2) KR102609790B1 (enExample)
CN (2) CN111183220B (enExample)
AU (2) AU2018272984B2 (enExample)
CA (2) CA3063828A1 (enExample)
DK (2) DK3630968T3 (enExample)
ES (2) ES2986557T3 (enExample)
FI (2) FI3630967T3 (enExample)
IL (2) IL270949B2 (enExample)
PL (2) PL3630967T3 (enExample)
PT (2) PT3630968T (enExample)
WO (2) WO2018215657A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3630968T (pt) * 2017-05-26 2024-07-30 Genovis Ab Enzimas para análise de glicanos
BR112021026789A2 (pt) * 2019-07-03 2022-05-10 Palleon Pharmaceuticals Inc Sialidases humanas recombinantes, proteínas de fusão de sialidase e métodos de uso das mesmas
CN112795583A (zh) * 2020-11-16 2021-05-14 上海大学 重组唾液酸外切酶的制备方法、表达基因、重组表达载体及构建方法
AU2022413663A1 (en) * 2021-12-15 2024-06-13 Danisco Us Inc. Compositions and methods involving proteases specific for mannose-modified proteins
WO2024118481A1 (en) * 2022-11-28 2024-06-06 Amgen Inc. Method of processing etanercept

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720165B2 (en) 2001-06-14 2004-04-13 Zyomix, Inc. Methods for making antibody fragments and compositions resulting therefrom
US7807174B2 (en) * 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
GB0624874D0 (en) 2006-12-13 2007-01-24 Hansa Medical Ab Treatment
EP2281036B1 (en) 2008-04-18 2013-02-27 New England Biolabs, Inc. Endoglyosidases that cleave o-linked glycans
EP2166085A1 (en) 2008-07-16 2010-03-24 Suomen Punainen Risti Veripalvelu Divalent modified cells
US20100255487A1 (en) * 2009-03-27 2010-10-07 Life Technologies Corporation Methods and apparatus for single molecule sequencing using energy transfer detection
GB201115841D0 (en) 2011-09-13 2011-10-26 Genovis Ab Protein and method
GB201316744D0 (en) 2013-09-20 2013-11-06 Genovis Ab Method
WO2016003795A1 (en) 2014-07-02 2016-01-07 New England Biolabs, Inc. Universal n-glycan binding reagent
WO2017052433A1 (en) 2015-09-24 2017-03-30 Saab Ab A modular fluid actuator system
WO2017134274A1 (en) 2016-02-04 2017-08-10 Ulrich Von Pawel-Rammingen New streptococcal proteases
PT3630968T (pt) * 2017-05-26 2024-07-30 Genovis Ab Enzimas para análise de glicanos

Also Published As

Publication number Publication date
PT3630967T (pt) 2024-08-21
AU2018272400A1 (en) 2019-12-05
ES2986910T3 (es) 2024-11-13
US11584922B2 (en) 2023-02-21
CN111183220A (zh) 2020-05-19
DK3630968T3 (da) 2024-07-29
KR102608876B1 (ko) 2023-11-30
US20200087643A1 (en) 2020-03-19
IL270950B1 (en) 2025-02-01
FI3630968T3 (fi) 2024-07-24
AU2018272984B2 (en) 2024-05-23
CN111183221B (zh) 2024-04-09
CN111183221A (zh) 2020-05-19
KR20200011955A (ko) 2020-02-04
EP3630967A1 (en) 2020-04-08
IL270949B1 (en) 2025-02-01
CA3063815A1 (en) 2018-11-29
EP3630967B8 (en) 2024-07-17
AU2018272400B2 (en) 2024-06-13
IL270950A (en) 2020-01-30
EP3630967B1 (en) 2024-06-12
PT3630968T (pt) 2024-07-30
IL270949A (en) 2020-01-30
JP2020521460A (ja) 2020-07-27
IL270949B2 (en) 2025-06-01
EP3630968A1 (en) 2020-04-08
IL270950B2 (en) 2025-06-01
WO2018215656A9 (en) 2019-03-14
WO2018215657A9 (en) 2019-03-14
PL3630968T3 (pl) 2024-10-07
JP7195008B2 (ja) 2022-12-23
US12448614B2 (en) 2025-10-21
US20200172889A1 (en) 2020-06-04
KR102609790B1 (ko) 2023-12-04
JP7557896B2 (ja) 2024-09-30
WO2018215656A1 (en) 2018-11-29
US20230212543A1 (en) 2023-07-06
CA3063828A1 (en) 2018-11-29
KR20200010322A (ko) 2020-01-30
CN111183220B (zh) 2024-03-22
JP2023103233A (ja) 2023-07-26
ES2986557T3 (es) 2024-11-11
PL3630967T3 (pl) 2024-11-18
JP2020522242A (ja) 2020-07-30
WO2018215657A1 (en) 2018-11-29
AU2018272984A1 (en) 2019-12-05
EP3630968B8 (en) 2024-07-03
EP3630968B1 (en) 2024-05-29
FI3630967T3 (fi) 2024-08-12

Similar Documents

Publication Publication Date Title
IL282704A (en) De novo binding domain containing polypeptides and uses thereof
DK3784283T3 (da) Cannabidiopræparater og anvendelser deraf
DK3625263T3 (da) Anti-galectin- 9-antistoffer og anvendelser deraf
DK3383916T3 (da) Anti-CD73-antistoffer og anvendelser deraf
DK3537765T3 (da) Fremgangsmåde og indretning til omskiftning
IL268593A (en) Polypeptide variants and uses thereof
IL265489B (en) Recombinant binding proteins and their uses
DK3268470T3 (da) Transposasepolypeptider og anvendelser deraf
DK3356413T3 (da) Anti-tigit-antigenbindingsproteiner og fremgangsmåder til anvendelse deraf
DK3471755T3 (da) Pegyleret svineinterferon og fremgangsmåder til anvendelse deraf
DK3303379T3 (da) Tigit-bindende midler og anvendelser deraf
DK3710484T5 (da) Ctla-4-bindende antistoffer og anvendelser deraf
DK3559227T3 (da) Proteasevarianter og anvendelser deraf
DK3551664T3 (da) Antistoffer og polypeptider rettet mod cd127
DK3280441T3 (da) Anti-sortilin-antistoffer og fremgangsmåder til anvendelse deraf
DK3412302T3 (da) Modificerede fgf-21-polypeptider og anvendelser deraf
DK3292150T3 (da) Aktiverbare anti-cd166-antistoffer og fremgangsmåder til anvendelse deraf
DK3668512T3 (da) Pyruvatkinasemodulatorer og anvendelse deraf
DK3157552T3 (da) Syntac-polypeptider og anvendelser deraf
DK3224603T3 (da) Nordning og fremgangsmåde til materialekarakteristik
DK3532499T3 (da) ANTI-IL-33-antistoffer og anvendelser deraf
DK3710067T3 (da) D-domæne indeholdende polypeptider og anvendelser deraf
DK3478712T5 (da) Anti-N3pGlu-amyloidbetapeptid-antistoffer og anvendelser deraf
DK3145945T3 (da) Hidtil ukendte specifikt bindende polypeptider og anvendelser deraf
DK3402821T3 (da) Psma-bindende antistof og anvendelser deraf